Zdrowie i gospodarka · 14/08/2026

FDA to Host Public Meeting on Reauthorization of Prescription Drug User Fee Act

The FDA is hosting a public meeting to discuss proposed recommendations for reauthorizing the Prescription Drug User Fee Act, which authorizes the agency to collect user fees to support the review of human drug applications, and to gather public comments on the proposals.